Patient-specific compartmental models for [177Lu]LuPSMA-617 therapy

被引：0
|
作者：
Li, W. [1 ]
Kupitz, D. [2 ,3 ]
Spielmann, V. [1 ]
Kamp, A. [1 ]
Katzdobler, L. [1 ]
Giussani, A. [1 ]
Kreissl, M. [2 ,3 ,4 ]
Grosser, O. [2 ,3 ,4 ]
机构：
[1] Bundesamt Strahlenschutz, Oberschleissheim, Germany
[2] Otto von Guericke Univ, Univ Hosp Magdeburg, Dept Radiol & Nucl Med, Magdeburg, Germany
[3] Otto von Guericke Univ, Fac Med, Magdeburg, Germany
[4] Otto von Guericke Univ, Res Campus STIMULATE, Magdeburg, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2024年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0920
引用
收藏
页码：S799 / S800
页数：2
相关论文
共 50 条
  • [21] Accuracy of two dosimetry software programs for 177Lu radiopharmaceutical therapy using voxel-based patient-specific phantoms
    Ramonaheng, Keamogetswe
    van Staden, Johannes A.
    du Raan, Hanlie
    HELIYON, 2022, 8 (07)
  • [22] Enhanced Therapeutic Effect of the Albumin-Binding [177Lu]Lu-Ibu-DAB-PSMA as Compared to [177Lu]Lu-PSMA-617-A Preclinical Therapy Study
    Tschan, V.
    Borgna, F.
    Schibli, R.
    Mueller, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S65 - S66
  • [23] Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial
    Herrmann, Ken
    Gafita, Andrei
    de Bono, Johann S.
    Sartor, Oliver
    Chi, Kim N.
    Krause, Bernd J.
    Rahbar, Kambiz
    Tagawa, Scott T.
    Czernin, Johannes
    El-Haddad, Ghassan
    Wong, Connie C.
    Zhang, Zhaojie
    Wilke, Celine
    Mirante, Osvaldo
    Morris, Michael J.
    Fizazi, Karim
    ECLINICALMEDICINE, 2024, 77
  • [24] Clinical dosimetry study of kidney absorbed radiation doses for [177Lu]Lu-PSMA-617 and [177Lu]Lu-PSMA-I&T
    Uijen, M.
    Prive, B.
    van Herpen, C.
    Gotthardt, M.
    Konijnenberg, M.
    Peters, S.
    Nagarajah, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S111 - S112
  • [25] Characterization of Non-Specific Uptake and Retention Mechanisms of [177Lu]Lu-PSMA-617 in the Salivary Glands
    Heynickx, Nathalie
    Segers, Charlotte
    Coolkens, Amelie
    Baatout, Sarah
    Vermeulen, Koen
    PHARMACEUTICALS, 2023, 16 (05)
  • [26] Patient-specific pharmacokinetics and dosimetry over multiple therapy cycles during 177Lu-based radionuclide therapy: a study for 177Lu-DOTATATE and 177Lu-PSMA
    Gosewisch, A.
    Ermoschkin, L.
    Ilhan, H.
    Todica, A.
    Vamacka, L.
    Bartenstein, P.
    Boening, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S270 - S271
  • [27] AUTOMATED RADIOSYNTHESIS OF [177LU]LU-PSMA-617 ON THE IPHASE MULTISYN MODULE
    Wichmann, C.
    Ackermann, U.
    Poniger, Stan
    Young, K.
    Chan, G.
    Hofman, M.
    Lee, S. T.
    Sachinidis, J.
    Scott, A.
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 31 - 32
  • [28] Automated radiosynthesis of [177Lu] Lu-PSMA-617 on the iPHASE MultiSyn module
    Wichmann, Christian
    Ackermann, Uwe
    Poniger, Stan
    Young, Kenneth
    Chan, James
    Hofman, Michael
    Sachinidis, John
    Scott, Andrew
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S329 - S329
  • [29] Comparison of different methods for post-therapeutic dosimetry in [177Lu]Lu-PSMA-617 radioligand therapy
    Rosar, Florian
    Schon, Niklas
    Bohnenberger, Hendrik
    Bartholoma, Mark
    Stemler, Tobias
    Maus, Stephan
    Khreish, Fadi
    Ezziddin, Samer
    Schaefer-Schuler, Andrea
    EJNMMI PHYSICS, 2021, 8 (01)
  • [30] Renal Safety of [177Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney Function
    Rosar, Florian
    Kochems, Niklas
    Bartholomae, Mark
    Maus, Stephan
    Stemler, Tobias
    Linxweiler, Johannes
    Khreish, Fadi
    Ezziddin, Samer
    CANCERS, 2021, 13 (12)
12345